Identifying Gaps in Real-World Management of Diabetes in Nigeria: A Subset Analysis of Cross-Sectional Wave-7 Data from the International Diabetes Management Practices Study
Endocrinology Unit, Department of Medicine, Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria
,
Endocrinology Unit, Department of Medicine, University of Abuja Teaching Hospital, Abuja, Nigeria
,
Endocrinology Unit, Department of Medicine, University of Port Harcourt Teaching Hospital, Port-Harcourt, Nigeria
1 Endocrinology Unit, Department of Medicine, Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria
2 Endocrinology Unit, Department of Medicine, University of Abuja Teaching Hospital, Abuja, Nigeria
3 Endocrinology Unit, Department of Medicine, University of Port Harcourt Teaching Hospital, Port-Harcourt, Nigeria
Background/Purpose: Poor glycemic control in Nigeria necessitates assessment and standardization of diabetes care. This study aimed to assess real-world management of people with type 2 diabetes mellitus (T2DM) and type 1 diabetes mellitus (T1DM) in Nigeria. Methods: This cross-sectional phase of the seventh wave of International Diabetes Management Practices Study, conducted between 22 nd August and 30 th September 2016, included adults with T1DM or T2DM during a two-week recruitment period. Results: Of 304 people with T2DM, 187 received oral glucose lowering drugs (OGLDs) only; 88 received OGLDs + insulin; 27 received insulin only. Metformin + sulfonylureas (128/187; 68.45%) and premix only (76/115; 66.09%) were the most used OGLD and insulin regimens respectively. Of 77 people with TIDM, all received insulin; six (7.79%) received OGLDs. Insulin initiation was noted around five years after diabetes diagnosis in T2DM (diabetes duration: 8.69 + 7.16 years; duration of insulin treatment: 3.17 ± 4.49 years). Proportion of people achieving glycemic targets (HbA1c < 7%: T2DM [66/202, 32.67%], T1DM [6/56, 10.71%]; clinical targets: T2DM [28/112, 25.00%], T1DM [14/74, 18.92%]; triple targets: T2DM [7/286, 2.45%], T1DM [3/64, 4.69%]) was low. Cost of medications/strips (92/144; 63.89%) and lack of experience in self-managing insulin (46/144; 31.94%) were main reasons for non-achievement of glycemic targets. Diabetes complications (253/372; 68.01%), hypoglycemia (symptomatic in the preceding three months: total = 97/373 [26.01%], T2DM = 61/300 [20.33%], T1DM = 36/73 [49.32%]; severe in the preceding 12 months: total = 32/368 [8.70%], T2DM = 17/298 [5.70%], T1DM = 15/70 [21.43%]) and hospitalizations (90/369; 24.39%) were common. Most participants (T2DM: 216/304 [71.05%]; T1DM: 62/76 [81.58%]) had a glucometer at home; few (T2DM: 44/113 [38.94%]; T1DM: 38/73 [52.05%]) self-managed both blood glucose and insulin. Conclusion: Early insulinization and subsidized healthcare can improve long-term diabetes outcomes in Nigeria.
KeywordsDiabetesManagement GapsNigeria
Federation ID (2017) IDF Diabetes Atlas. Brussels. http://www.diabetesatlas.org
Ogbera, A.O. and Ekpebegh, C. (2014) Diabetes Mellitus in Nigeria: The Past, Present and Future. World Journal of Diabetes, 5, 905-911. https://doi.org/10.4239/wjd.v5.i6.905
Uloko, A.E., Musa, B.M., Ramalan, M.A., et al. (2018) Prevalence and Risk Factors for Diabetes Mellitus in Nigeria: A Systematic Review and Meta-Analysis. Diabetes Therapy, 9, 1307-1316. https://doi.org/10.1007/s13300-018-0441-1
Uloko, A.E., Ofoegbu, E.N., Chinenye, S., et al. (2012) Profile of Nigerians with Diabetes Mellitus—Diabcare Nigeria Study Group (2008): Results of a Multicenter Study. Indian Journal of Endocrinology and Metabolism, 16, 558-564. https://doi.org/10.4103/2230-8210.98011
Federation ID (2000) IDF Diabetes Atlas 2000. https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/24-atlas-1st-edition.html
Federation ID (2015) IDF Diabetes Atlas 2015. 7th Edition.
Adeloye, D., Ige, J.O., Aderemi, A.V., et al. (2017) Estimating the Prevalence, Hospitalisation and Mortality from Type 2 Diabetes Mellitus in Nigeria: A Systematic Review and Meta-Analysis. BMJ Open, 7, e015424. https://doi.org/10.1136/bmjopen-2016-015424
Guariguata, L., Whiting, D.R., Hambleton, I., et al. (2014) Global Estimates of Diabetes Prevalence for 2013 and Projections for 2035. Diabetes Research and Clinical Practice, 103, 137-149. https://doi.org/10.1016/j.diabres.2013.11.002
Mbanya, J.C., Motala, A.A., Sobngwi, E., Assah, F.K. and Enoru, S.T. (2010) Diabetes in Sub-Saharan Africa. The Lancet (London, England), 375, 2254-2266. https://doi.org/10.1016/S0140-6736(10)60550-8
Dahiru, T., Aliyu, A.A. and Shehu, A. (2016) A Review of Population-Based Studies on Diabetes Mellitus in Nigeria. Sub-Saharan African Journal of Medicine, 3, 59-64. https://doi.org/10.4103/2384-5147.184351
Association ID (2013) IDF Diabetes Atlas. 6th Edition.
Ngwogu, K., Mba, I. and Ngwogu, A. (2012) Glycaemic Control amongst Diabetic Mellitus Patients in Umuahia Metroppolis, Abia State, Nigeria. International Journal of Basic, Applied and Innovative Research, 1, 98-104.
Adibe, M.O., Anosike, C., Nduka, S.O. and Isah, A. (2018) Evaluation of Health Status of Type 2 Diabetes Outpatients Receiving Care in a Tertiary Hospital in Nigeria. Pharmacoecon Open, 2, 337-345. https://doi.org/10.1007/s41669-017-0056-x
Identifying Gaps in Real-World Management of Diabetes in Nigeria: A Subset Analysis of Cross-Sectional Wave-7 Data from the International Diabetes Management Practices Study — Oak Academic Publishing
Fasanmade, O.A. and Dagogo-Jack, S. (2015) Diabetes Care in Nigeria. Annals of Global Health, 81, 821-829. https://doi.org/10.1016/j.aogh.2015.12.012
Oguejiofor, O. (2014) Diabetes in Nigeria: Impact, Challenges, Future Directions. Endocrinology & Metabolic Syndrome, 3, Article No. 130. https://doi.org/10.4172/2161-1017.1000130
Davies, M.J., D’Alessio, D.A., Fradkin, J., et al. (2018) Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care, 41, 2669-2701. https://doi.org/10.2337/dci18-0033
Inzucchi, S.E., Bergenstal, R.M., Buse, J.B., et al. (2015) Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 38, 140-149. https://doi.org/10.2337/dc14-2441
Ogu, R., Chinenye, S. and Korubo, I. (2015) Diabetes Advocacy and Care in Nigeria: A Review Sunday Chinenye, Rosemary Ogu, Ibitrokoemi Korubo. The Nigeria Health Journal, 15, Article No. 145.
Okoro, E.O., Adejumo, A.O. and Oyejola, B.A. (2002) Diabetic Care in Nigeria: Report of a Self-Audit. Journal of Diabetes and Its Complications, 16, 159-164. https://doi.org/10.1016/S1056-8727(01)00145-3
World Medical Association (2013) World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA, 310, 2191-2194. https://doi.org/10.1001/jama.2013.281053
Goodyear, L.J. (2008) The Exercise Pill—Too Good to Be True? New England Journal of Medicine, 359, 1842-1844. https://doi.org/10.1056/NEJMcibr0806723
Abioye-Kuteyi, E.A., Ojofeitimi, E.O., Ijadunola, K.T. and Fasanu, A.O. (2005) Assessment of Dietary Knowledge, Practices and Control in Type 2 Diabetes in a Nigerian Teaching Hospital. Nigerian Journal of Medicine: Journal of the National Association of Resident Doctors of Nigeria, 14, 58-64. https://doi.org/10.4314/njm.v14i1.37137
Ntui, I., Udoh, A.E., Esiere, K.-U.S., Essien, O. and Egbe, E.R. (2006) The Pattern of Dietary Habits and Glycemic Control of Diabetics in Eastern Nigeria. Pakistan Journal of Nutrition, 5, 43-45. https://doi.org/10.3923/pjn.2006.43.45
Ezeani Ignatius, U., Onyeonoro, U.U., Ugwu, T.E., Chuku, A. and Aihanuwa, E. (2017) Challenges with Insulin Use among Patients with Type 2 Diabetes Mellitus: Focus on a Tertiary Healthcare Setting in South-East Nigeria. Current Diabetes Reviews, 13, 175-181. https://doi.org/10.2174/1573399812666151016110355
Owens, D.R. (2013) Clinical Evidence for the Earlier Initiation of Insulin Therapy in Type 2 Diabetes. Diabetes Technology & Therapeutics, 15, 776-785. https://doi.org/10.1089/dia.2013.0081
Ufuoma, C., Godwin, Y.D., Kester, A.D. and Ngozi, J.C. (2016) Determinants of Glycemic Control among Persons with Type 2 Diabetes Mellitus in Niger Delta. Sahel Medical Journal, 19, Article No. 190. https://doi.org/10.4103/1118-8561.196361
Stephani, V., Opoku, D. and Beran, D. (2018) Self-Management of Diabetes in Sub-Saharan Africa: A Systematic Review. BMC Public Health, 18, Article No. 1148. https://doi.org/10.1186/s12889-018-6050-0
Mbanya, J.C., Naidoo, P., Kolawole, B.A., Tsymbal, E., McMaster, A., Karamchand, S., et al. (2020) Management of Adult Patients with Type 1 Diabetes Mellitus in Africa: A Post-Hoc Cohort Analysis of 12 African Countries Participating in the International Diabetes Management Practices Study (Wave 7). Medicine (Baltimore), 99, e20553. https://doi.org/10.1097/MD.0000000000020553
Olamoyegun, M.A., Akinlade, A.T. and Ala, O.A. (2018) Audit of Insulin Prescription Patterns and Associated Burden among Diabetics in a Tertiary Health Institution in Nigeria. African Health Sciences, 18, 852-864. https://doi.org/10.4314/ahs.v18i4.3
Awodele, O. and Osuolale, J.A. (2015) Medication Adherence in Type 2 Diabetes Patients: Study of Patients in Alimosho General Hospital, Igando, Lagos, Nigeria. African Health Sciences, 15, 513-522. https://doi.org/10.4314/ahs.v15i2.26